Marty Norman

Marty Norman has extensive experience in clinical quality assurance and vendor management. They are currently the Director of Clinical Quality Assurance at Apnimed since January 2023. Prior to that, they held the same position at Harpoon Therapeutics from March 2022 to December 2022. Marty also worked as the Associate Director of Clinical Quality Assurance, Vendor Management & Quality Agreements at Kiniksa Pharmaceuticals from January 2021 to January 2022. They previously held the role of Senior Manager of Clinical Quality Assurance at Celgene Bristol Myers Squibb from April 2015 to January 2021. Marty's career began at M Norman, where they worked as a Clinical Research Specialist and Compliance Project Manager from January 2007 to April 2015.

Marty Norman holds a Bachelor of Arts (BA) degree in Psychology from UC Irvine. The start and end years for this education are not available.